Connect with us

Technology

Elon Musk says SpaceX will attempt to recover Super Heavy rocket by catching it with launch tower – Yahoo Finance Australia

SpaceX will try a significantly different approach to landing its future reusable rocket boosters, according to CEO and founder Elon Musk. It will attempt …

Published

on

post featured image

The agency also provided specific guidance for inclusion/exclusion criteria for patients seeking leronlimab under eIND authorizationVANCOUVER, Washington, Dec. 30, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (CytoDyn or the Company”), a late-stage biotechnology company developing Vyrologix (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the U.S. Food and Drug Administration (FDA) has accepted the protocol submitted on December…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending